Charles River Laboratories International, Inc. (FRA:RV6)
| Market Cap | 7.06B -13.3% |
| Revenue (ttm) | 3.41B -0.9% |
| Net Income | -122.69M |
| EPS | -2.48 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 15.09 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 0 |
| Open | 139.65 |
| Previous Close | 133.70 |
| Day's Range | 139.65 - 139.65 |
| 52-Week Range | 87.70 - 193.70 |
| Beta | n/a |
| RSI | 33.52 |
| Earnings Date | Feb 18, 2026 |
About FRA:RV6
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, ins... [Read more]
News
Charles River Laboratories International Inc (CRL) Shares Down 6.04% on Feb 5
Charles River Laboratories International Inc (CRL) Shares Down 6.04% on Feb 5
Zurcher Kantonalbank (Zurich Cantonalbank) Sells 14,014 Shares of Charles River Laboratories ...
Zurcher Kantonalbank (Zurich Cantonalbank) Sells 14,014 Shares of Charles River Laboratories International Inc (CRL)
Victory Growth and Tax Strategy Fund Buys 489 Shares of Charles River Laboratories ...
Victory Growth and Tax Strategy Fund Buys 489 Shares of Charles River Laboratories International Inc (CRL)
Templeton Global Smaller Companies Fund Buys 92,523 Shares of Charles River Laboratories ...
Templeton Global Smaller Companies Fund Buys 92,523 Shares of Charles River Laboratories International Inc (CRL)
AE Wealth Management LLC Buys 1,480 Shares of Charles River Laboratories International Inc (CRL)
AE Wealth Management LLC Buys 1,480 Shares of Charles River Laboratories International Inc (CRL)
Patriot Financial Group Insurance Agency, LLC Sells 2,120 Shares of Charles River Laboratories ...
Patriot Financial Group Insurance Agency, LLC Sells 2,120 Shares of Charles River Laboratories International Inc (CRL)
Goldman Sachs Strategic Factor Allocation Fund Buys 834 Shares of Charles River Laboratories ...
Goldman Sachs Strategic Factor Allocation Fund Buys 834 Shares of Charles River Laboratories International Inc (CRL)
Apollon Wealth Management, LLC Buys 1,454 Shares of Charles River Laboratories International ...
Apollon Wealth Management, LLC Buys 1,454 Shares of Charles River Laboratories International Inc (CRL)
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Buys 884,691 Shares of Charles River Laboratories ...
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Buys 884,691 Shares of Charles River Laboratories International Inc (CRL)
RICHARDSON FINANCIAL SERVICES INC. Buys 118 Shares of Charles River Laboratories International ...
RICHARDSON FINANCIAL SERVICES INC. Buys 118 Shares of Charles River Laboratories International Inc (CRL)
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call.
Charles River (CRL) Expands Gene Therapy Collaboration with Gazi University
Charles River (CRL) Expands Gene Therapy Collaboration with Gazi University
Charles River Enters Manufacturing Collaboration with Gazi University
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract developme...
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
NEW YORK and NEW ORLEANS, Jan. 20, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy
Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Charles River Laboratories International Inc at JPMorgan Healthcare Conference Transcript
Charles River Laboratories International Inc at JPMorgan Healthcare Conference Transcript
Evercore ISI Group Raises Price Target for Charles River (CRL) to $260 | CRL Stock News
Evercore ISI Group Raises Price Target for Charles River (CRL) to $260 | CRL Stock News
EQS-News: Healthcare Specialist SHS Capital agreed to sell PathoQuest to strategic buyer Charles River Laboratories
Issuer: SHS Gesellschaft für Beteiligungsmanagement mbH / Key word(s): Disposal/Private Equity Healthcare Specialist SHS Capital agreed to sell PathoQuest to strategic buyer Charles River Laboratories...
Charles River Laboratories Announces Strategic Acquisitions And Leadership Appointment
(RTTNews) - Charles River Laboratories International Inc. (CRL) unveiled a series of strategic moves at the J.P. Morgan 44th Annual Healthcare Conference, including two planned acquisitions, a key lea...
Charles River (CRL) Advances with Strategic Acquisitions and Leadership Update
Charles River (CRL) Advances with Strategic Acquisitions and Leadership Update
Charles River to buy Cambodia-based monkey supplier for $510 million
Charles River Laboratories said on Monday it would buy one of its major suppliers of non-human primates for about $510 million as the contract research firm seeks greater control over procurement of t...
Charles River Laboratories Provides Business Updates
Charles River Laboratories International, Inc. (NYSE: CRL) today announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandjé N. Bumpus as Chief Scientif...
Charles River Laboratories Provides Business Updates
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Provides Business Updates.
Charles River Laboratories (CRL) Announces Leadership Transition
Charles River Laboratories (CRL) Announces Leadership Transition